Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intestinal drug transporters in pathological states: an overview
Marek Droździk, Izabela Czekawy, Stefan Oswald, et al.
Pharmacological Reports (2020) Vol. 72, Iss. 5, pp. 1173-1194
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Colonic drug delivery: Formulating the next generation of colon-targeted therapeutics
Laura E. McCoubrey, Alessia Favaron, Atheer Awad, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 1107-1126
Open Access | Times Cited: 110
Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance
John O. Miners, Thomas M. Polasek, Julie-Ann Hulin, et al.
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108459-108459
Closed Access | Times Cited: 30
Structured edible lipid-based particle systems for oral drug-delivery
Areen Ashkar, Alejandro Sosnik, Maya Davidovich‐Pinhas
Biotechnology Advances (2021) Vol. 54, pp. 107789-107789
Closed Access | Times Cited: 52
Mitochondrial DNA Release Contributes to Intestinal Ischemia/Reperfusion Injury
Shishi Liao, Jie Luo, Tulanisa Kadier, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Intestinal membrane transporter-mediated approaches to improve oral drug delivery
Rudra Pangeni, Soim Kang, Saurav Kumar Jha, et al.
Journal of Pharmaceutical Investigation (2021) Vol. 51, Iss. 2, pp. 137-158
Closed Access | Times Cited: 34
The impact of advanced age on gastrointestinal characteristics that are relevant to oral drug absorption: An AGePOP review
Cordula Stillhart, Adam Asteriadis, E.N. Bocharova, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 187, pp. 106452-106452
Open Access | Times Cited: 16
Beyond nanoparticle-based oral drug delivery: transporter-mediated absorption and disease targeting
Hana Cho, Kang Moo Huh, Hyun Ji Cho, et al.
Biomaterials Science (2024) Vol. 12, Iss. 12, pp. 3045-3067
Open Access | Times Cited: 5
The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery
Jingyi Li, Yaqi Zhang, Miaorong Yu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1460-1472
Open Access | Times Cited: 30
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting
Camille Lenoir, Jean Terrier, Yvonne Gloor, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 526-526
Open Access | Times Cited: 20
Physiologically based pharmacokinetic (PBPK) modelling of oral drug absorption in older adults – an AGePOP review
Cleo Demeester, Donnia Robins, Angela Elma Edwina, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 188, pp. 106496-106496
Open Access | Times Cited: 12
The Effect of Inflammatory Bowel Disease and Irritable Bowel Syndrome on Pravastatin Oral Bioavailability: In vivo and in silico evaluation using bottom-up wbPBPK modeling
Mo’tasem M. Alsmadi, Alla A. Abudaqqa, Nasir Idkaidek, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 4
Closed Access | Times Cited: 4
Transporter Proteins as Therapeutic Drug Targets—With a Focus on SGLT2 Inhibitors
Nina Komaniecka, Sonia Maroszek, Maria Droździk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6926-6926
Open Access | Times Cited: 4
Protein abundance of drug transporters and drug-metabolizing enzymes in paired healthy and tumor tissue from colorectal cancer patients
Sebastian Steigert, Joachim Brouwers, Tim Vanuytsel, et al.
International Journal of Pharmaceutics (2025), pp. 125216-125216
Closed Access
Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1
Yang Wang, Liuxin Qin, Weiwei Chen, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113806-113806
Closed Access | Times Cited: 26
Renal and non-renal response of ABC and SLC transporters in chronic kidney disease
Adriana M. Torres, Ankur V. Dnyanmote, Jeffry C. Granados, et al.
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 5, pp. 515-542
Closed Access | Times Cited: 21
Intestinal ABC transporters: Influence on the metronomic cyclophosphamide-induced toxic effect in an obese mouse mammary cancer model
María Manuela Barranco, Felipe Zecchinati, Virginia Perdomo, et al.
Toxicology and Applied Pharmacology (2024), pp. 117130-117130
Closed Access | Times Cited: 2
An Oral 3D Printed PLGA-Tocopherol PEG Succinate Nanocomposite Hydrogel for High-Dose Methotrexate Delivery in Maintenance Chemotherapy
Pierre P. D. Kondiah, Thankhoe A. Rants’o, Sifiso S. Makhathini, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1470-1470
Open Access | Times Cited: 10
Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters
Kexin Lin, Xiaorui Kong, Xufeng Tao, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5252-5252
Open Access | Times Cited: 6
Extrahepatic Drug Transporters in Liver Failure: Focus on Kidney and Gastrointestinal Tract
Marek Droździk, Stefan Oswald, Agnieszka Droździk
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5737-5737
Open Access | Times Cited: 14
Gutsy science: In vitro systems of the human intestine to model oral drug disposition
Christopher M. Arian, Tomoki Imaoka, Jade Yang, et al.
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107962-107962
Open Access | Times Cited: 12
Role of the Intestinal Microbiota in the Genesis of Major Depression and the Response to Antidepressant Drug Therapy: A Narrative Review
Tiziana Mundula, Simone Baldi, Elisabetta Gerace, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 550-550
Open Access | Times Cited: 4
Digestive Tract and Salivary Glands
Christy A. McKnight, Lauri Diehl, Ingrid L. Bergin
Elsevier eBooks (2024), pp. 1-148
Closed Access | Times Cited: 1
An extension of biorelevant fed-state dissolution tests to clinical pharmacokinetics – A study on gastrointestinal factors influencing rivaroxaban exposure and efficacy in atrial fibrillation patients
Michał Romański, Joanna Giebułtowicz, Elżbieta Gniazdowska, et al.
International Journal of Pharmaceutics (2023) Vol. 649, pp. 123626-123626
Closed Access | Times Cited: 3
Influence of schisantherin A on the pharmacokinetics of lenvatinib in rats and its potential mechanism
Yanjun Cui, Yinling Ma, Ying Li, et al.
Journal of Gastrointestinal Oncology (2022) Vol. 13, Iss. 2, pp. 802-811
Open Access | Times Cited: 5
C3435T Polymorphism of the ABCB1 Gene in Polish Patients with Inflammatory Bowel Disease: A Case–Control and Meta-Analysis Study
Paweł Petryszyn, Robert Dudkowiak, Agnieszka Gruca, et al.
Genes (2021) Vol. 12, Iss. 9, pp. 1419-1419
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top